SMMT — SUMMIT THERAPEUTICS INC

Ownership history in SUPERSTRING CAPITAL MANAGEMENT LP  ·  3 quarters on record

This page tracks every 13F SEC filing in which SUPERSTRING CAPITAL MANAGEMENT LP reported a position in SUMMIT THERAPEUTICS INC (SMMT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
4.01% (2025 Q3)
Avg. % of fund
3.2%
First filed
2024 Q4
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 197,253 +65,234 +49.4% 4.01% $4.1M $20.66
2025 Q1 REDUCED 132,019 -32,545 -19.8% 3.03% $2.5M $19.29
2024 Q4 INITIATED 164,564 — — 2.54% $2.9M $17.84
% of Fund (quarterly)    SMMT price (monthly, adj. close)

Other funds also holding SMMT

As of 2025 Q4 — sorted by position size

APEIRON CAPITAL Ltd 3Y 26.48% BAKER BROS. ADVISORS LP 3Y 7Y 3.73% Polymer Capital Management (HK) LTD 3.54% SECTORAL ASSET MANAGEMENT INC 3Y 7Y 1.12% Rock Springs Capital Management LP 3Y 7Y 0.64% QVT Financial LP 3Y 7Y 0.54% Capstone Capital Management Ltd 0.47% GRIFFIN ASSET MANAGEMENT, INC. 3Y 7Y 0.37% Affinity Asset Advisors, LLC 3Y 0.35% AXQ CAPITAL, LP 3Y 0.32%
← Back to SUPERSTRING CAPITAL MANAGEMENT LP Holdings